Arcutis Biotherapeutics's total assets for Q4 2025 were $432.97M, an increase of 16.71% from the previous quarter. ARQT total liabilities were $243.49M for the fiscal quarter, a 14.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.